Heparin protects basic and acidic FGF from inactivation
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The ability of heparin or that of hexuronyl hexosaminoglygan sulfate (HHS‐4) to protect basic or acidic fibroblast growth factor (FGF) from acid or heat inactivation has been analyzed. Both freshly prepared basic and acidic FGF stimulate the growth of baby hamster kidney (BHK‐21) cells exposed to medium supplemented with transferrin and insulin. Freshly prepared basic FGF was 10 fold more potent than acidic FGF. The addition of heparin to the medium decreased the potency of basic FGF while it potentiated that of acidic FGF. Upon storage of FGF at −80°C, a decline in potency of both basic and acidic FGF was observed. Heparin, when added to the medium, potentiated their activities, which became similar to that of freshly prepared basic FGF. In order to test whether heparin could protect basic or acidic FGF from inactivation, both mitogens were exposed to acid conditions (1% trifluoroacetic acid, pH 1.08, 2 h) or heat (65°C, 5 min) which inactivate basic or acidic FGF. When exposed to such treatment in the presence of heparin or HHS‐4, basic and acidic FGF retained their potency. The effect of heparin and HHS‐4 on the bioactivity of basic and acidic FGF is truly of a protective nature, since they had no effect when added after inactivation of the mitogens. Potentiation of the bioactivity of the protected mitogens or of the inactivated one could only be observed when cells were exposed to high heparin or HHS‐4 concentrations. This indicates that heparin and HHS‐4, in addition to protecting FGF from inactivation, also acts at another locus, as yet unidentified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of FGF-2 to heparan sulfate also imparts stability to the growth factor.”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [40]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Markwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
Epidermal Growth Factor and a New Derivative
Savage, C. R., & Cohen, S. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44568-7 · Cited by 1,208
Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., & Klagsbrun, M. (1984) · Science · doi:10.1126/science.6199844 · Cited by 933
Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial Cultivation
Thornton, S. C., Mueller, S. N., & Levine, E. M. (1983) · Science · doi:10.1126/science.6635659 · Cited by 793
Esch, F., Baird, A., Ling, N., Ueno, N., Hill, F., Denoroy, L., Klepper, R., Gospodarowicz, D., Böhlen, P., & Guillemin, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6507 · Cited by 693
Self-citationCultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth
Castellot, J., Addonizio, M., Rosenberg, R., & Karnovsky, M. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.90.2.372 · Cited by 679
Gospodarowicz, D., Cheng, J., Lui, G. M., Baird, A., & Böhlent, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6963 · Cited by 613
Self-citationPurification of a fibroblast growth factor from bovine pituitary.
Gospodarowicz, D. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41631-1 · Cited by 591
Self-citationPurification of the fibroblast growth factor activity from bovine brain.
Gospodarowicz, D., Bialecki, H., & Greenburg, G. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34863-9 · Cited by 492
Self-citation
Research works printed but not linked: 1
- Gospodarowicz D., 1986, Methods in Enzymology
Cited by
Items 701–800 of 902
Loret, C., Laeng, P., Sensenbrenner, M., & Labourdette, G. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81562-5 · Cited by 10
Shain, S. A., & Koger, J. (1989) · PubMed · Cited by 10
VEGF-modified PLA/HA nanocomposite fibrous membrane for cranial defect repair in rats
Wang, Y., Li, H., Zhao, C., Zi, Q., He, F., & Wang, W. (2023) · Journal of Biomaterials Applications · doi:10.1177/08853282231198157 · Cited by 9
Modulation of Short-Term Delivery of Proteins from Hydrogels
Ahrens, L., Forget, A., & Shastri, V. P. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c15185 · Cited by 9
Nano-Structure Analysis of Sugar Chains by Small Angle X-ray Scattering
Yuguchi, Y. (2009) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.21.1 · Cited by 9
Stem cells cardiac differentiation in 3D systems
Spadaccio, C., Rainer, A., Chachques, J. C., Covino, E., Herreros, J., & Genovese, J. A. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/195 · Cited by 9
Beierle, J. M., Yoshimatsu, K., Chou, B., Mathews, M. A. A., Lesel, B. K., & Shea, K. J. (2014) · Angewandte Chemie · doi:10.1002/ange.201404881 · Cited by 9
Takahara, J.-I., Hosoya, K., Sunako, M., Hirohara, S., Terada, K., Ando, T., & Tanihara, M. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.02.052 · Cited by 9
Gaultier, C. J., & Michel, J. (1999) · Basic science for the cardiologist · doi:10.1007/978-0-585-38146-6_6 · Cited by 9
Bauer, R. J., Der, K., Ottah, N., Barrientos, J., & Kung, A. H. C. (1997) · Pharmaceutical Research · doi:10.1023/a:1012013113759 · Cited by 9
Kajio, T., Kawahara, K., & Kato, K. (1992) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/1056-8719(92)90059-a · Cited by 9
The effect of growth factors on the cytotoxicity of sulphated polysaccharides
Kunou, M., & Hatanaka, K. (1997) · Carbohydrate Polymers · doi:10.1016/s0144-8617(97)00114-8 · Cited by 9
Inhibition of BC3H-1 cell growth by heparin is related to decreased mitogenic signalling
Vannucchi, S., Pasquali, F., Chiarugi, V. P., & Ruggiero, M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91244-m · Cited by 9
Heparin potentiation of the effect of acidic fibroblast growth factor on astrocytes and neurons
Shao, N., Wang, H., Tingchong, Z., Yanning, X., & Liu, C. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00447-1 · Cited by 9
Hatanaka, K., Ohtsuki, T., & Kunou, M. (1994) · Chemistry Letters · doi:10.1246/cl.1994.1407 · Cited by 9
Characterizing the Mitogenic Effect of Basic Fibroblast Growth Factor in the Adult Rat Striatum
Hagood, S., McGinn, M. J., Sun, D., & Colello, R. J. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.205 · Cited by 9
“Heparin sulfate facilitates the binding of bFGF to its receptors and retards the degradation of bFGF in the extracellular space (Gospodarowicz and Cheng, 1986; Saksela et al., 1988).”
Immunoglobulin E, Mast Cells, Endogenous Antigens, and Arthritis
Gruber, B. L. (1991) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00574-3 · Cited by 9
Wissink, M. J. B. (1999) · University of Twente Research Information · doi:10.3990/1.9789036513159 · Cited by 9
Effect of heparin-binding growth factors on monovalent cation transport in Balb/C 3T3 cells
Halperin, J. A., & Lobb, R. R. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(87)80483-7 · Cited by 9
Heparan sulfate as a central modulator of growth factor dynamics in tissue regeneration
Tao, K., Shokoohmand, A., Cool, S. M., & Smith, R. A. A. (2025) · APL Bioengineering · doi:10.1063/5.0289409 · Cited by 8
Roser, S. M., Munarin, F., Polucha, C., Minor, A. J., Choudhary, G., & Coulombe, K. L. K. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c01823 · Cited by 8
Ghourichaee, S. S., & Leach, J. B. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb02701b · Cited by 8
Luría-Pérez, R., Candelaria, P. V., Daniels‐Wells, T. R., Rodríguez, J. A., Helguera, G. F., & Penichet, M. L. (2019) · Cytokine · doi:10.1016/j.cyto.2019.04.004 · Cited by 8
“Gospodarowicz D, Cheng J, Heparin protects basic and acidic FGF from inactivation, J Cell Physiol 128(3) (1986) 475–84.”
BackgroundLennon, A. M., Esfandiari, A., Gavaret, J., Courtin, F., & Pierre, M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62062116.x · Cited by 8
“If heparin is present, the level stays stable for at least up to 24 h, due perhaps to the effect of heparin on the proteolytic inactivation of FGFs (Gospodarowicz and Cheng, 1986).”
BackgroundSuramin and heparin: aspecific inhibitors of mesoderm induction in the Xenopus laevis embryo
Cardellini, P., Polo, C., & Coral, S. (1994) · Mechanisms of Development · doi:10.1016/0925-4773(94)90054-x · Cited by 8
Liu, X., Zhao, J., Wang, Y., Liu, T., Lü, F., & He, G. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.05.005 · Cited by 8
“In this regard, a number of methods have been explored, including the use of control-released biomaterials [6, 7, 10–13], heparin co-application capable of protecting bFGF from enzymic degradation [12, 14], and the route of administration [15–20].”
BackgroundMethodGrowth Factors in the Gastrointestinal Tract
Kuemmerle, J. F., Barnard, J. A., & McHugh, K. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00008-7 · Cited by 8
The usefulness of CHAPS as a non-cytotoxic stabilizing agent in purification of growth factors
Matuo, Y., Nishi, N., Muguruma, Y., Yoshitake, Y., Masuda, Y., Nishikawa, K., & Wada, F. (1988) · Cytotechnology · doi:10.1007/bf00365076 · Cited by 8
“Gospodarowicz and Cheng [15] reported the protection of FGFs from inactivation by heparin.”
BackgroundDimitrellos, V., Lamari, F. N., Militsopoulou, M., Kanakis, I., & Karamanos, N. K. (2003) · Biomedical Chromatography · doi:10.1002/bmc.208 · Cited by 8
Growth factors in wound healing
Robinson, C. J. (1992) · Trends in biotechnology · doi:10.1016/0167-7799(92)90253-r · Cited by 8
Demonstration of a basic fibroblast growth factor-like molecule in mouse hepatic endothelial cells
Rosenbaum, J., Mavier, P., Préaux, A.-M., & Dhumeaux, D. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91782-8 · Cited by 8
Fibroblast Growth Factor: Molecular and Biological Properties
Gospodarowicz, D., & Neufeld, G. (1987) · Springer eBooks · doi:10.1007/978-3-642-71837-3_16 · Cited by 8
Self-citationIshihara, M., Kishimoto, S., Takikawa, M., Mori, Y., Nakamura, S., & Fujita, M. (2011) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2011.225061 · Cited by 7
“The polysaccharides can prolong the biological halflife of FGF-2 as well as protect FGF-2 from heat, acid, and proteolytic inactivation [22].”
BackgroundHague, A., & Jones, G. E. (2007) · Cell Biology and Toxicology · doi:10.1007/s10565-007-9049-3 · Cited by 7
Liu, X., Shi, S., Chen, J., Wu, D., Kan, M., Myoken, Y., Okamoto, T., & Sato, J. D. (2002) · Springer eBooks · doi:10.1007/978-94-017-0728-2_61 · Cited by 7
Photo-crosslinking hyaluronan-heparin hybrid hydrogels for BMP-2 sustained delivery
He, T., Wu, D., Wang, X., Rong, J., & Zhao, J. (2016) · Journal of Polymer Engineering · doi:10.1515/polyeng-2015-0379 · Cited by 7
Growth Factors in the Gastrointestinal Tract
Barnard, J. A., & McHugh, K. M. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50010-6 · Cited by 7
Kishimoto, S., Oonuma, F., Nakamura, S., Hattori, H., Nakamura, S., Mori, Y., Tanaka, Y., Harada, Y., TAGAWA, M., & Ishihara, M. (2009) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31486 · Cited by 7
Shain, S. A., Lin, A., & Wong, G. (1992) · PubMed · Cited by 7
Evidence for the colocalization of the axonal mitogen for Schwann cells and oligodendrocytes
Mason, P. W., Chen, S. ‐., & Vries, G. H. D. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490260305 · Cited by 7
Spears, J. R., Yellayi, S. S., Makkar, R., Nallamothu, N., Rizvi, M. A. D., Sheriff, M. U., Khetpal, V., Zhan, H., Jang, J., Kundu, S. K., et al. (1994) · Lasers in Surgery and Medicine · doi:10.1002/lsm.1900140406 · Cited by 7
Donohue, P. J., Hsu, D. K. W., Guo, Y., Burgess, W. H., & Winkles, J. A. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3598 · Cited by 7
Fibroblast growth factor and transforming growth factor beta in early embryonic development
Paterno, G. D., & Gillespie, L. L. (1989) · Progress in Growth Factor Research · doi:10.1016/0955-2235(89)90002-1 · Cited by 7
Zhu, G. (1999) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 7
Growth Factors for Vascular Endothelial Cells
Gospodarowicz, D. (1990) · Springer eBooks · doi:10.1007/978-3-642-75262-9_16 · Cited by 7
“In recent studies, heparin has been shown to protect both bFGF and aFGF from acid or heat inactivation [28].”
BackgroundSelf-citationGeist, A., Marx, J., Müller, S., Uzan, A., van Specht, B. U., & Haberstroh, J. (2005) · European Surgical Research · doi:10.1159/000087862 · Cited by 6
“Fibroblast growth factor-1 (FGF-1), a member of a family of heparin-binding molecules, is a major inducer of neovascularization (angiogenesis) and can be activated by exogenous heparin which favors the formation of ternary complexes of FGF-1 with its cellular receptors [”
BackgroundYuguchi, Y., Kominato, R., Ban, T., Urakawa, H., Kajiwara, K., Takano, R., Kamei, K., & Hara, S. (2004) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2004.11.003 · Cited by 6
Preparation and characterization of bFGF and BSA-loaded microspheres
Çetin, M., Çapan, Y., Vural, İ., Doğan, A. L., Guc, D., Hıncal, A. A., Wehrlé, P., & Dalkara, T. (2005) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(05)50067-4 · Cited by 6
Non-Anticoagulant Actions of Glycosaminoglycans (GAGs)
Cornelli, U. (1996) · Springer eBooks · doi:10.1007/978-1-4613-0371-8_20 · Cited by 6
Gallagher, J. T., & Dexter, T. M. (1989) · Springer eBooks · doi:10.1007/978-1-4613-8862-3_7 · Cited by 6
Cancre, I., Wormhoudt, A. V., & Gal, Y. L. (1999) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/s0742-8413(99)00036-5 · Cited by 5
Kersten, J. R., & Warltier, D. C. (1995) · Journal of Cardiac Surgery · doi:10.1111/j.1540-8191.1995.tb00623.x · Cited by 5
Human Basic Fibroblast Growth Factor: Structure-Function Relationship of an Angiogenic Molecule
Presta, M., Rusnati, M., Gualandris, A., Dell’Era, P., Urbinati, C., Coltrini, D., Tanghetti, E., & Belleri, M. (1994) · Springer eBooks · doi:10.1007/978-1-4757-9188-4_5 · Cited by 5
Biophysical and structural analysis of human acidic fibroblast growth factor
Blaber, M., Adamek, D. H., Popović, A. R., & Blaber, S. I. (1997) · Techniques in protein chemistry · doi:10.1016/s1080-8914(97)80073-7 · Cited by 5
Neurotrophic Factors and Neurodegeneration
Martin, J. (1995) · Springer eBooks · doi:10.1007/978-1-4471-1871-8_12 · Cited by 5
Emoto, N., Shimizu, K., Onose, H., Ishii, S., Sugihara, H., & Wakabayash, I. (2000) · Thyroid · doi:10.1089/thy.2000.10.843 · Cited by 5
Pettmann, B., Janet, T., Labourdette, G., Sensenbrenner, M., Manthowe, M., & Varon, S. S. (1991) · Growth Factors · doi:10.3109/08977199109000285 · Cited by 5
Yang, C., & Chou, S. (1993) · Journal of Receptor Research · doi:10.3109/10799899309073702 · Cited by 5
Fibroblast Growth Factor Receptors
Ornitz, D. M., & Waksman, G. (1997) · Springer eBooks · doi:10.1007/978-1-4612-1876-0_9 · Cited by 5
Regeneration of the Auditory Nerve: The Role of Neurotrophic Factors
Water, T. R. V. D., Staecker, H., Apfel, S. C., & Lefebvre, P. P. (1996) · Springer handbook of auditory research · doi:10.1007/978-1-4612-4068-6_3 · Cited by 5
Synthesis and application of phenol-grafted rhamnan sulfate for 3D bioprinting
Goto, R., Terasawa, M., Kojima, M., Matsuda, K., Nishiura, K., & Sakai, S. (2024) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2024.2427499 · Cited by 4
“In nature, endogenous FGF-2 is protected from inactivation by native sulfated polysaccharides, such as heparin and heparan sulfate, which are present on the cell surface and in the extracellular matrix [37].”
Fibroblast growth factor and kidney disease: Updates for emerging novel therapeutics
Trivedi, N., & Kumar, D. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30497 · Cited by 4
“Heparin‐like molecules protect basic FGF from denaturation and enzymatic degradation, so these com- pounds may be used to strengthen the FGF signal (Gospodarowicz & Cheng, 1986; Takasato et al., 2015).”
BackgroundBiomaterial-based systems as biomimetic agents in the repair of the central nervous system
Collazos-Castro, J. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00007-6 · Cited by 4
Buğra, K., Olivier, L., Jacquemin, E., Laurent, M., Courtois, Y., & Hicks, D. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00602.x · Cited by 4
Li, Y., Liu, X.-H., & Cai, L. (2007) · PubMed · Cited by 4
Brain-Metastasis Associated Genes
Marchetti, D. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47821-8_5 · Cited by 4
Yao, C., & Pallua, N. (2003) · RWTH Publications (RWTH Aachen) · Cited by 4
Sheng, H., Shah, P. K., & Audus, K. L. (1996) · Pharmaceutical Research · doi:10.1023/a:1016035513974 · Cited by 4
The Interaction of Basic Fibroblast Growth Factor (bFGF) With Heparan Sulfate Proteoglycans
Rusnati, M., Coltrini, D., Oreste, P., Zoppetti, G., & Presta, M. (1996) · Springer eBooks · doi:10.1007/978-1-4613-0371-8_13 · Cited by 4
Berthet, M. (2017) · theses.fr (ABES) · doi:10.70675/db99d319z56fcz49e6zb112zdd1f6e4a81e6 · Cited by 4
Cytokines in breast cancer cell dyshesion
Tamm, I., Kikuchi, T., Cardinale, I. R., Murphy, J. S., & Krueger, J. G. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8946-9_2 · Cited by 4
Goto, R., Sakai, S., Delattre, C., Petit, E., Elboutachfaiti, R., & Nakahata, M. (2024) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2024.08.011 · Cited by 3
Growth factors and cytokines in tumor invasion and metastasis
Beckner, M. E., & Liotta, L. A. (1997) · Growth factors and cytokines in health and disease · doi:10.1016/s1874-5687(97)80014-6 · Cited by 3
Polymeric Drug Delivery Systems in Tissue Engineering
Skiles, M. L., & Blanchette, J. O. (2013) · Wiley eBooks · doi:10.1002/9781118747896.ch8 · Cited by 3
Myocardial Ischemia and Infarction
Tomanek, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4887-7_10 · Cited by 3
Therapeutic Coronary Angiogenesis
Flanagan, M. F. (1999) · Advances in organ biology · doi:10.1016/s1569-2590(08)60169-x · Cited by 3
Mane, S., Winkelmann, J. C., & Luikart, S. D. (1991) · PubMed · Cited by 3
Cohen, M. V., Chukwuogo, N. A., & Yarlagadda, A. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199308000-00002 · Cited by 3
Weise, S., & Justus Liebig University Giessen (2001) · doi:10.22029/jlupub-10626 · Cited by 3
Regulation of Protease Nexin-1 Activity and Target Protease Specificity by the Extracellular Matrix
Cunningham, D. D., Farrell, D. H., & Wagner, S. L. (1990) · Springer eBooks · doi:10.1007/978-1-4684-8357-4_9 · Cited by 3
Fibroblast growth factors in ischemic stroke: Therapeutic potential and clinical challenges
Dordoe, C., Kai-ming, G., Bwalya, C., Huang, W., Chen, S., Chen, J., Wang, X., Wang, P., Li, X., & Li, L. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01832-7 · Cited by 2
“A common characteristic of this family is their ability to bind to heparin and heparin-sulfates, which protect them from degradation [21].”
Masuzawa, Y., & Kitazawa, M. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100929 · Cited by 2
“It is known that heparin protects basic and acidic FGF from acid- and heat-induced inactivation [12].”
BackgroundControlled Angiogenic Factor Release from Alginate Gels
Lee, K. Y., Nishishita, N., Hirano, Y., & Mooney, D. J. (2007) · Key engineering materials · doi:10.4028/www.scientific.net/kem.342-343.517 · Cited by 2
Fibroblast (Heparin-Binding) Growing Factors in Neuronal Development and Repair
Haynes, L. W. (1989) · Humana Press eBooks · doi:10.1007/978-1-4612-4520-9_10 · Cited by 2
Yuan, X. F., Li, R., Rao, Z., Li, H., Rong, J., Tu, M., Zeng, R., & Zhao, J. (2016) · International Journal of Polymeric Materials · doi:10.1080/00914037.2016.1180609 · Cited by 2
Nagasaki, T., & Lieberman, M. A. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90094-e · Cited by 2
Human cutaneous mast cells in health and disease. (I).
Kubota, Y. (1997) · The Nishinihon Journal of Dermatology · doi:10.2336/nishinihonhifu.59.609 · Cited by 2
Acidic Polysaccharides Having Biological Activities
Minamisawa, T., & Hatanaka, K. (1996) · Sen i Gakkaishi · doi:10.2115/fiber.52.p63 · Cited by 2
Growth factor induction of epithelial cell proliferation and matrix metalloproteinase secretion
Putnins, E. E. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0088405 · Cited by 2
Wang, N. (1997) · VTechWorks (Virginia Tech) · Cited by 2
Extracellular histone H3: biomarker and therapeutic target for the prevention of tissue damage
Beurskens, D. M. H. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200320db · Cited by 2
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00004-4 · Cited by 2
Lyons-Giordano, B., Brinker, J. M., & Kefalides, N. A. (1992) · Springer eBooks · doi:10.1007/978-1-4899-0721-9_4 · Cited by 2
Angiogenesis: Its Regulation in Health and Disease
Banskota, N. K., & King, G. L. (1993) · E&M. Endocrinology and metabolism · doi:10.1007/978-1-4613-9272-9_1 · Cited by 1
Regulation of Angiogenesis in Cancer and Its Therapeutic Implications
Han, L., Lorincz, A. M., & Sukumar, S. V. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-184-0_20 · Cited by 1
“Released FGF binds to heparin, which not only protects FGF from proteolytic degradation but forms an FGF reservoir ( 50 , 51).”
BackgroundZhang, L. (2009) · Deep Blue (University of Michigan) · Cited by 1
Effects of Heparin on the Vessel Wall and Blood Cellular Elements
Bergqvist, D., & Siegbahn, A. (1993) · Vascular Medicine Review · doi:10.1177/1358863x9300400305 · Cited by 1
Polymeric gels for tissue engineering applications
Chameettachal, S., & Pati, F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-102179-8.00012-0 · Cited by 1
Cornelli, U., Hanin, I., Lorens, S. A., Fareed, J., Lee, P., Mervis, R. F., Piccolo, P., & Cornelli, M. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_25 · Cited by 1
Metadata
- Authors
- Gospodarowicz, D., & Cheng, J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Gospodarowicz, D.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 1986-09
- Volume
- 128
- Issue
- 3
- Pages
- 475-484
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W1972855766
- Cited by
- 853
- References
- 30
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 11 · 2021: 13 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 8 · 2016: 18 · 2015: 10 · 2014: 9 · 2013: 11 · 2012: 22
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 20197)
- National Eye Institute (EY02186)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- heparin, basic fibroblast growth factor, acidic fibroblast growth factor, acid inactivation, thermal inactivation
- MeSH terms
- Animals, Cell Division, Cell Line, Fibroblast Growth Factors, Fibroblasts, Glycosaminoglycans, Cricetinae, Hot Temperature, Heparin, Hydrogen-Ion Concentration, Insulin, Kidney, Mesocricetus, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.